Indiana University Research and Technology Corporation
发明人:
申请号：
EP15175377.9
公开号：
EP2952202A1
申请日:
2009.06.16
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Glucagon peptides that exhibit GIP agonist activity in addition to glucagon and/or GLP-1 activity are provided. Pharmaceutical compositions comprising such glucagon peptides and therapeutic methods of using such peptides are also provided.
